Activated Carbon Market Target Emerging Industries by 2024: Grand View Research Inc.

San Francisco, 1 February 2019: The Report Activated Carbon Market Size, Share & Trends Analysis Report By Product (Powdered Activated Carbon, Granular Activated Carbon), By Application, By End-use, And Segment Forecasts, 2018 – 2024

The global activated carbon market is expected to reach USD 10.15 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for air & water purification in the coal-fired plants, clinker cement industries is expected to drive the demand for granular and powdered activated carbon.

Activated carbon possesses a high degree of micro porosity and adsorption properties, owing to which it is preferred in air and water purification across various end-use industries. Applications in the removal of mercury, acid gas toxins along with metallic emissions from coal & oil powered plants are expected to fuel industry growth. Rising concerns regarding drinking water safety along with a shift in trend towards adopting healthy lifestyle are anticipated to drive market demand.

Increasing environmental pollution due to industrial and vehicular emissions is projected to fuel air purification segment. Water treatment applications include municipal treatment, domestic water filters, and groundwater remediation. Food & beverage industry uses activated carbon to remove odor & color from various products. These carbons are used in pharmaceutical industry to cure poisoning due to toxins ingestions.

Various regulations promoting the use of activated carbons in air and water treatments plants are expected to trigger demand over the forecast period. U.S. EPA regulations governing mercury emissions from coal power plants are projected to drive the activated carbon consumption over the next eight years. EU waste water directives regulate water pollution and wastewater from municipal and industrial sources.

Access Research Report of Activated Carbon Market @ www.grandviewresearch.com/industry-analysis/activated-carbon-market

Further key findings from the report suggest:

·       The global activated carbon market demand was 1,684.3 kilo tons in 2015 and is expected to reach 5,092.2 kilo tons by 2024, growing at a CAGR of 13.3% from 2016 to 2024

·       Powdered activated carbon emerged as the leading product segment with demand share estimated at 59.1% in 2015. It is also expected to witness the highest growth of 14.2% over the forecast period.

·       Air purification was the leading end-use segment and accounted for over 40% of total demand in 2015. Growing awareness regarding health benefits of air filtration coupled with regulations such as Clean Air Act is expected to drive this segment. It is also expected to witness the highest growth of 15.0% over the next eight years

·       Water & wastewater treatment is also expected to brisk growth over the forecast period. The growth can be attributed to increasing applications in municipal plants, ground water remediation, and beverage industry.

·       Asia Pacific was the leading regional market with demand share exceeding 40% in 2015. Increasing usage in air & water purification and emergence of novel applications such as pharmaceutical and food & beverage industry in the region is expected to drive the product demand.

·       Key market participants include Kureha Corporation, Carbon Activated Corporation, ADA-ES Inc., Haycarb PLC, Carbotech, Carbon Resources LLC, Cabot Corporation, MeadWestvaco Corporation, and Calgon Carbon Corporation.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/water-and-industrial-sludge-treatment

Grand View Research has segmented the global activated carbon market on the basis of product, application, end-use and region:

Global Activated Carbon Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

·         Powdered Activated Carbon

·         Granulated Activated Carbon

·         Others

Global Activated Carbon Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

·         Liquid Phase

·         Gas Phase

Global Activated Carbon End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

·         Water Treatment

·         Food & Beverage Processing

·         Pharmaceutical & Medical

·         Automotive

·         Air purification

Global Activated Carbon Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Central & South America

·         Middle East & Africa

Access Press Release of Activated Carbon Market@ www.grandviewresearch.com/press-release/global-activated-carbon-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cervical Cancer Treatment Market is Anticipated to Register 5.0% CAGR through 2025: Grand View Research Inc.

San Francisco, 1 February 2019: The Report Cervical Cancer Treatment Market Size, Share & Trends Analysis Report By Type (SCC, Adenocarcinoma), By Product (Prevention, Treatment), By Distribution Channel (Online, Hospital Pharmacies), And Segment Forecasts, 2018 - 2025

The global cervical cancer treatment market size is expected to reach USD 10.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to record a CAGR of 5.0% over the forecast period. Increased treatment penetration and rising disease incidence are projected to drive the market growth over the next few years. Although, sexually transmitted HPV is a major cause, the disease can also be triggered by other factors, such as oral contraceptives, multiple sexual partners, smoking, and HIV infection. There are more than 100 strains of HPV, 13 of which are high-risk or cancerous. Squamous cell carcinoma is the most common type and it accounts for nearly 85% of the overall cases.

The differentiation between squamous cell carcinoma and adenocarcinoma is based on the histology, as observed under the microscope. Cervical adenosquamous carcinoma is rare, involving a mixture of squamous and glandular tissues. Products for cervical cancer can be broadly classified into prevention and treatment. Preventive options involve vaccines against HPV. Currently, there are two commercial vaccines – Gardasil and Cervarix. Treatment options include biologics, such as Avastin and generics like topotecan, cisplatin, bleomycin, fluorouracil, paclitaxel, carboplatin, and doxorubicin. The development of targeted therapeutics with improved efficacy and reduced cost remains a key unmet need of this market. Nevertheless, expanding focus on the research and development in oncology, including cervical cancer, indicate a promising future for this market.

Access Research Report of Cervical Cancer Treatment Market @ www.grandviewresearch.com/industry-analysis/cervical-cancer-treatment-market

Further key findings from the study suggest:

·       HPV affects nearly 95% of all cervical cancer cases. HPV strains 16 and 18 account for nearly 70% of all cases reported

·       Nearly three-fourth of all cases occur in developing and underdeveloped regions (mostly, in Asia and Africa), where healthcare facilities are limited and awareness about diagnosis and treatment is low

·       North America was the dominant region in the global cervical cancer treatment market and is expected to continue its dominance over the estimated period

·       This growth is attributed to growing target population patient, increasing market penetration of drugs, and easy accessibility to advanced treatments

·       Some of the key companies in the market include F. Hoffmann-LA Roche AG; Merck & Co., Inc.; GlaxoSmithKline PLC; Allergan PLC; Pfizer, Inc.; Biocon Ltd.; Bristol-Myers Squibb Company; AstraZeneca PLC; and Eli Lilly & Co.

·       Merck & Co. led the competitive space and is likely to continue to be the largest shareholder due to strong commercial performances of Gardasil and Keytruda

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global cervical cancer treatment market on the basis of type, product, distribution channel, and region:

Cervical Cancer Treatment Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Squamous Cell Carcinoma (SCC)

·         Adenocarcinoma

·         Adenosquamous Carcinoma

Cervical Cancer Treatment Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Prevention

·         Treatment

Cervical Cancer Treatment Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

Cervical Cancer Treatment Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Press Release of Cervical Cancer Treatment Market@ www.grandviewresearch.com/press-release/global-cervical-cancer-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bowel Management System Market To Hold a High Potential for Growth by 2025: Grand View Research Inc.

San Francisco, 1 February 2019: The Report Bowel Management Systems Market Size, Share & Trends Analysis Report By Product (Colostomy Bags, Irrigation Systems, Nerve Modulation Devices), By Patient Type, By End Use, And Segment Forecasts, 2018 - 2025

The global bowel management system market is expected to reach USD 2.25 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.3% during the forecast period. Rising incidence of fecal incontinence coupled with growing government initiatives to raise awareness about bowel management is likely to drive the market. Furthermore, favorable reimbursement scenario has also been favoring the growth of the market.

Bowel management systems are an important tool to manage fecal incontinence. According to the International Foundation for Gastrointestinal Disorders, fecal incontinence affects 6.9% of adult females and 7.4% of adult males. It has also been estimated that around 20.0% of people with irritable bowel syndrome have bowel incontinence.

In addition, different organizations such as United Ostomy Associations of America, Inc. and Colostomy U.K. are working towards raising awareness about ostomy. They are focused on empowering and supporting people who have had ostomy. Also, government bodies globally are introducing programs to provide support to individuals with a stoma by improving access to clinically appropriate and most suitable stoma-related products. These are some of the factors that are promoting the growth of the market.

Access Research Report of Bowel Management System Market @ www.grandviewresearch.com/industry-analysis/bowel-management-systems-market

Further key findings from the report suggest:

·       Colostomy bags were the largest segment in 2017 and are likely to witness the fastest growth over the forecast period due to factors such as their high usage rate and well-structured reimbursement policies across developed regions

·       The adult segment dominated the market in terms of revenue in 2017 owing to factors such as high prevalence of fecal incontinence among adults

·       The home care segment was the leading segment in the market in 2017, owing to rising adoption of bowel management products in home care settings. The segment is also poised to witness the highest CAGR during the forecast period

·       North America and Europe accounted for sizeable cumulative share in the market in 2017. These regions experience high usage rate of bowel management systems and are marked by presence of significant key players such as 3M and Medtronic

·       Asia Pacific is expected to exhibit the fastest growth during the forecast period due to unmet clinical needs and need for better diagnosis

·       Some of the prominent players operating in this space are Mederi Therapeutics Inc.; Aquaflush Medical Limited; Medtronic; Coloplast; C.R. Bard; 3M; Consure Medical; B. Braun; Cogentix Medical; ConvaTec; Axonics Modulation Technologies; Welland Medical Limited; MBH-International A/S; and Wellspect HealthCare

·         Key players are adopting strategies such as expanding their geographic reach, increasing R&D activities, rising number of collaborations, growing awareness programs, technological advancements, and launching new products to increase their market share.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global bowel management system market on the basis of product, patient type, end use, and region:

Bowel Management System Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Colostomy Bags

·         Irrigation Systems

·         Nerve Modulation Devices

·         Others

Bowel Management System Patient Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Adult

·         Pediatric

Bowel Management System End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Home Care

·         Hospitals and Ambulatory Surgery Centers

Bowel Management System Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Bowel Management System Market@ www.grandviewresearch.com/press-release/global-bowel-management-systems-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Biopsy Devices Market Strong Application and Emerging Trends also Scope by 2020: Grand View Research Inc.

San Francisco, 31 January 2019: The Report Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, Competitive Landscape, And Segment Forecasts, 2012 - 2020

The global biopsy devices market size is expected to reach USD 2.3 billion by 2020, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.4% during the forecast period. Growing incidence of cancer, rising geriatric population across the world, and soaring demand for less invasive biopsy procedures are some of the key trends stimulating market growth. 

Demand for minimally invasive biopsy procedures is rising at a significant rate in the market. Different types of technologies and products such as, biopsy guiding systems, needle-based biopsy guns, and vacuum assisted devices are anticipated to witness high growth during the forecast period.

North America is likely to command a considerable revenue share in the market throughout the forecast period. On the other hand, Asia Pacific is projected to post a noteworthy CAGR during the same period.

In emerging economies, high price of biopsy devices can hinder the growth of the market. Patients in the countries are generally price sensitive and need more efficient and effective medical technologies and facilities. There are several regulatory changes coming across the world to address unmet needs of patients in these areas.

High unmet patient needs coupled with rapidly improving healthcare infrastructure in emerging countries such as India and China are poised to augment the regional market. Advent of technologically advanced and efficient products such as Vacora and Finesse Ultra Breast Biopsy System by BARD and Celero VAB device by Hologic Inc. is stoking the growth of the market. Besides this, burgeoning popularity of these devices in developed countries such as the U.S., Canada, and Japan are expected to boost the growth of the overall market during the forecast period.

Some of the key players in the biopsy devices market are Inard Inc.; Carefusion Corporation; Devicor Medical Products, Inc; DTR Medical; Hologic Inc.; C.R. Bard Inc. and Cardinal Health Inc. These companies are involved in developing and adding technologically advanced and cost effective instruments to their product portfolio.

Access Research Report of Biopsy Devices Market@ www.grandviewresearch.com/industry-analysis/biopsy-devices-industry

Further key findings from the report suggest:

·       Due to rapid technological advancements and high efficiency, biopsy guidance systems are anticipated to register sharp rise in their demand over the forecast period

·       Surging demand for less invasive surgeries and disposable biopsy devices is one of the primary growth stimulants for the market

·       Technologies such as vacuum assisted biopsy devices are able to facilitate easy removal of large tissue samples. Upsurge in their demand will influence the overall market positively

·       The North America market was at the forefront of the market. The region is driven by various factors such as better infrastructure, patient awareness, and good healthcare facilities

·       Asia Pacific is estimated to emerge as the fastest growing region in the global arena.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global biopsy devices market based on product and region:

Biopsy Devices Product Outlook (Revenue USD Million, 2012 - 2020)

·         Needle-based Biopsy Guns

·         Biopsy Guidance Systems

·         Biopsy Needles

·         Biopsy Forceps

·         Others

Biopsy Devices Regional Outlook (Revenue USD Million, 2012 - 2020)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

Access Press Release of Biopsy Devices Market@ www.grandviewresearch.com/press-release/biopsy-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com